Allogenetics develops biotechnology solutions focused on genetic engineering and cell therapy. The company aims to address unmet medical needs with advanced therapies and products.
Founded
2022
Total Funding
$1M+
Total Rounds
1
First Raise
Sep 9, 2026
Latest Raise
Sep 9, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/9/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free